baber/WOPTO huggingface dataset:
Patent AU-2021200497-A1 (AU)
Title: Bump Stopper.
Inventor: DAY LINCOLN
IPC: B60D1/60
Filed: 2021-01-27
Abstract: The present disclosure provides a quantum control pulse generation method and 
apparatus, a device, a storage medium, and a product, which are related to the field of 
quantum computation. The method is specifically implemented as follows: constructing, 
based on relevant physical parameters of a target quantum hardware structure, a system 
Hamiltonian of a quantum system characterized by the target quantum hardware structure; 
obtaining an initial control pulse set matching the target quantum hardware structure; 
obtaining, based on the system Hamiltonian, system state information of the quantum 
system by simulation, wherein the system state information characterizes state information 
of the quantum system obtained by simulation after an application of the initial control 
pulse to the qubit in the target quantum hardware structure; and optimizing the initial 
control pulse in the initial control pulse set based on at least a relationship between the 
system state information of the quantum system and target state information that needs to 
be achieved by the target quantum task, to obtain a target control pulse sequence by 
simulation. In this way, quantum computing software and quantum computing hardware 
are combined to achieve a specific quantum task.  
(FIG. 1)
S101 
constructing, based on relevant physical parameters of a target quantum 
hardware structure, a system Hamiltonian of a quantum system 
characterized by the target quantum hardware structure, wherein the target 
quantum hardware structure is used to achieve a target quantum task 
S102 
obtaining an initial control pulse set matching the target quantum hardware 
structure, wherein the initial control pulse set comprises at least one initial 
control pulse used to be applied to a qubit in the target quantum hardware 
structure 
S103 
obtaining, based on the system Hamiltonian, system state information of the 
quantum system by simulation, wherein the system state information 
characterizes state information of the quantum system obtained by 
simulation after an application of the initial control pulse to the qubit in the 
target quantum hardware structure 
S104 
optimizing the initial control pulse in the initial control pulse set based on at 
least a relationship between the system state information of the quantum 
system and target state information that needs to be achieved by the target 
quantum task, to obtain a target control pulse sequence by simulation 
FIG. 1 
1/7
Patent AU-2021200756-A1 (AU)
Title: Blood Clot Removal Device, System, And Method
Inventor: FORSELL PETER
IPC: A61F2/01
Filed: 2021-02-05
Abstract: A blood clot removal device for removing blood clots from the vascular system of a patient is 
implantable in the patient's body. The blood clot removal device comprises a blood flow passageway 
to be connected to the patient's vascular system to allow circulation of the patient's blood through the 
blood flow passageway, a filter provided in the blood flow passageway for collecting blood clots 
occurring in the blood flowing through the blood flow passageway, and a cleaning device for moving 
blood clots collected by the filter out of the blood flow passageway. By means of such blood clot 
removal device, the risk of blood clots reaching sensitive areas of the patient's body, such as the brain, 
is reduced.
1/15 
1 
4 Uu 
3 
2b 3a 
10 
2a 
10a 2b 
f 
2 
Fig. 1
Patent AU-2021202619-A1 (AU)
Title: Multifunctional inhibitors of MEK/PI3K and mTOR/MEK/PI3K biological pathways and therapeutic methods using the same
Inventor: ROSS BRIAN D
IPC: A61P35/00
Filed: 2021-04-28
Abstract: Multifunctional inhibitors of mTOR, MEK, and P13K and compositions containing the 
same are disclosed. Methods of using the multifunctional inhibitors in the treatment of 
diseases and conditions wherein inhibition of one or more of mTOR, MEK, and P13K 
provides a benefit, like cancers, also are disclosed.
Patent AU-2021202981-A1 (AU)
Title: Quantum neural network
Inventor: NEVEN HELMUT
IPC: G06N3/063
Filed: 2021-05-11
Abstract: A quantum neural network architecture. In one aspect, a quantum neural network trained to 
perform a machine learning task includes: an input quantum neural network layer comprising 
(i) multiple qubits prepared in an initial quantum state encoding a machine learning task data 
input, and (ii) a target qubit; a sequence of intermediate quantum neural network layers, each 
intermediate quantum neural network layer comprising multiple quantum logic gates that 
operate on the multiple qubits and target qubit; and an output quantum neural network layer 
comprising a measurement quantum gate that operates on the target qubit and provides as 
output data representing a solution to the machine learning task.  
25
Patent AU-2021203874-A1 (AU)
Title: Treatment of Microbial Infections
Inventor: O'FLAHERTY VINCENT
IPC: A61K33/18
Filed: 2021-06-10
Abstract: The present application relates to an anti-microbial system for use in the treatment of 
microbial infections or control of microbial contamination, which avoids the use of 
antibiotics. Such infections include mastitis, tuberculosis, cystic fibrosis and the 
contamination that may result from biofilm formation on medical devices.  
Hydrogen Perwdde Only 
-lu 
Tim (hurs) 
Fig L Suseptibiy of E coh to imhibftiti by %02. Growth, measured by optical density at 595 am, was inhibited at dilutior of Us 
and 1/16, but not 13
Patent AU-2021212131-A1 (AU)
Title: Lock devices, systems and methods
Inventor: MCKIBBEN AARON P
IPC: E05B47/06
Filed: 2021-08-06
Abstract: Disclosed are various embodiments of lock devices, systems, and methods, lock of the application can 
include an internal mechanism to permit backdriven operation and lost motion operation. In one form 
the lock can be made from an assembly of parts that have locating features that require one way 
installation/assembly. The lock can include an internal power source capable of driving electronics 
used to determine handedness of a door.
Patent AU-2021225204-A1 (AU)
Title: Sound damping structural support system
Inventor: SESSLER JON
IPC: E04B1/98
Filed: 2021-09-02
Abstract: OF THE DISCLOSURE 
An acoustic damping structural system includes studs, tracks, and 
acoustic damping members. The studs and tracks include a first wall, a second wall, 
and a third wall that define a channel. The third wall includes a first portion 
5 perpendicular to the first wall, a second portion perpendicular to the first portion, and a 
third portion perpendicular to the second portion to define a ledge along a length of the 
third wall. The tracks are coupled to a support, such as floor joists and roof beams, in 
parallel. Opposite ends of the studs are received in the channels of the tracks, with the 
acoustic damping members received on and coupled to the ledges of pairs of the studs 
0 and pairs of the tracks. The acoustic damping members are planar with the ledges and 
the studs and tracks, respectively.  
27
1/7 
100 
loo 102 
117 
110 102 
117 
104 
116F 
102 
1004 102 
106 117 
FIG. I
Patent AU-2021245142-A1 (AU)
Title: User interface for loyalty accounts and private label accounts for a wearable device
Inventor: VAN OS MARCEL
IPC: G06Q20/34
Filed: 2021-10-06
Abstract: The present disclosure generally relates to the use of loyalty accounts, private label payment 
accounts, and general payment accounts using a wearable electronic device with an electronic 
wallet. Various accounts are linked to the electronic device. In some examples, the electronic 
device is NFC-enabled. The electronic device may be used to provide loyalty account 
information and payment account information to a payment terminal, such as an NFC-enabled 
payment terminal.
Patent AU-2021253451-A1 (AU)
Title: Vitality dietary supplement
Inventor: SEIDENSTICKER KURT
IPC: A23L33/18
Filed: 2021-04-01
Abstract: The present invention is directed to improving immune function by improving or increasing the function of immune cells, promoting adequate hydration, and supplying essential nutrients and amino acids that the immune system requires to function. The supplement composition of the present invention comprises: Collagen Peptides, l-glutamine, l-arginine, Baker's Yeast Beta Glucan, l-tryptophan, Heat-Killed Lactobacillus plantarum, vitamins, and minerals. Immune system function is improved using this combination of components.
Patent AU-2021261049-A1 (AU)
Title: Products of manufacture and methods for treating, ameliorating or preventing microbial infections
Inventor: BORODY THOMAS JULIUS
IPC: A61K31/215
Filed: 2021-04-23
Abstract: Provided are products of manufacture fabricated or manufactured as medical devices such as an inhaler, an ionizer, an asthma "puffer-like" device, a nebulizer or a nasal spray device, a respirator or a ventilator, a warm or a hot air delivery device, and/or a CPAP (continuous positive air pressure) device or equivalent, for delivering one or a combination of medications or drugs, and optionally also warm or hot air, and optionally also ionized air. Said drug combinations include various combinations of antivirals, antiparasitics, antibacterials, and adjunct therapeutics, including at least one of Hydroxychloroquine, Chloroquine, Oseltamivir, Lopinavir, Ritonavir, Ribavirin, Favipiravir, Remdesivir, Azithromycin, Ivermectin, Doxycycline, and Opaganib or combinations thereof. Products of manufacture are used for treating, preventing, ameliorating, slowing the progress of, decreasing the severity of or preventing a microbial infection, such as bacterial and viral infections, including the common respiratory viruses such as influenza vims, respiratory syncytial vims, picornavims, parainfluenza vims, adenovims, rhinovims, human metapneumovims, hantavimses, enterovims, a coronavims infection, or a COVID-19 or a 2019-nCoV (SARS-CoV-2) infection, or an infection caused by a vims in the subfamily Orthocoronavirinae, or a vims in the family Coronaviridae, or a vims in the order Nidovirales. In alternative embodiments, products of manufacture as provided herein administer combinations, or cocktails, of a dmg or dmgs by inhalation, for example, by use of aerosol, mist, liquid or powder formulations for inhalation.
Patent AU-2021296781-A1 (AU)
Title: Patient-monitoring system
Inventor: BIVANS MATTHEW
IPC: A61B5/00
Filed: 2021-06-22
Abstract: The invention provides an IV system for monitoring a patient that is positioned on the patient's body. The IV system includes: 1) a catheter that inserts into the patient's venous system; 2) a pressure sensor connected to the catheter that measures physiological signals indicating a pressure in the patient's venous system; 3) a motion sensor that measures motion signals; and 4) a processing system that: i) receives the physiological signals from the pressure sensor; ii) receives the motion signals from the motion sensor; iii) processes the motion signals by comparing them to a pre-determined threshold value to determine when the patient has a relatively low degree of motion; and iv) process the physiological signals to determine a physiological parameter when the processing system determines that the motion signals are below the pre-determined threshold value.
Patent AU-2021309476-A1 (AU)
Title: System and method for determining unwanted call origination in communications networks
Inventor: QUILICI ALEXANDER E
IPC: H04M3/22
Filed: 2021-07-12
Abstract: A method and system for discovering and locating the source of unwanted communication origination in a communications network, the method comprising compiling a communication campaign database storing data of one or more communication campaigns along with automatically identified instances of those campaigns, and simultaneously or sequentially matching those instances against known communication traffic of a set of cooperating telecommunication carriers. The one or more communications campaigns include a grouping of related fingerprints and patterns that identify a sequence of characters, audio or video associated with instances of a same likely campaigns, either legitimate or illegitimate/fraudulent.
Patent AU-2021319209-A1 (AU)
Title: Differentiation of pancreatic endocrine cells
Inventor: HARB GEORGE
IPC: C07K14/475
Filed: 2021-07-30
Abstract: Disclosed herein are compositions and methods related to differentiation of stem cells into pancreatic endocrine cells. In some aspects, the methods provided herein relate to generation of pancreatic β cell, a cell, δ cells, and EC cells
Patent AU-2021334114-A1 (AU)
Title: Set control composition for cementitious systems
Inventor: LORENZ KLAUS
IPC: C04B28/16
Filed: 2021-08-25
Abstract: A set control composition for cementitious systems comprises a retarder (a) selected from (a-1) polymeric polycarboxylic acids selected from homopolymers and copolymers of α,β-ethylenically unsaturated carboxylic acids; and copolymers of at least one a, β-ethylenically unsaturated carboxylic acid and at least one sulfo group containing monomer; and salts thereof, whose milliequivalent number of carboxyl groups is 3.0 meq/g or higher, preferably 3.0 to 17.0 meq/g, and having a molecular weight 25,000 g/mol or less, assuming all the carboxyl groups to be in unneutralized form, (a-2) phosphonic acids and salts thereof, (a-3) low molecular weight polycarboxylic acids and salts thereof, and mixtures thereof, (b) at least one of (b-1) a borate source and (b-2) a carbonate source, wherein the carbonate source is selected from inorganic carbonates having an aqueous solubility of 0.1 g-L·1 or more at 25 °C, and organic carbonates, in a weight ratio of b) to a) in the range of 0.1 to 10, (c) a polyol having at least 3 alcoholic hydroxyl groups in its molecule, in a weight ratio of c) to a) in the range of 0.2 to 4, and (d) a dispersant. The set control composition effectively improves workability of cementitious systems for prolonged periods of time without compromising early compressive strength. The compositions show sufficient open time, i.e., the time until initial setting, good workability during said open time as characterized, for example by adequate slump flow over time, and fast setting. The invention further relates to a construction composition comprising i) a cementitious binder comprising one or more calcium silicate mineral phases and one or more calcium aluminate mineral phases, ii) optionally, an extraneous aluminate source, iii) a sulfate source, and iv) the set control composition. The construction composition contains 0.05 to 0.2 mol of total available aluminate, calculated as AI(OH)4~ from the calcium aluminate mineral phases plus the optional extraneous aluminate source, per 100 g of cementitious binder i), and the molar ratio of total available aluminate to sulfate is 0.4 to 2.0.
Patent AU-2021360643-A1 (AU)
Title: Laryngoscope and intubation methods
Inventor: MOLNAR ROBERT W
IPC: A61B1/267
Filed: 2021-10-12
Abstract: In one aspect, this disclosure relates to a laryngoscope having a channel for delivering an endotracheal tube to the trachea and its placement under continuous visualization by a camera and with controlled suction. The laryngoscope may further comprise one or more additional channels, including a suction and camera channel. In another aspect, this disclosure relates to medical systems comprising one of laryngoscopes according to this disclosure and one or more of adapters, tools and/or cameras.
Patent AU-2021372815-A1 (AU)
Title: Combination treatment of cancer
Inventor: SALA-HOJMAN ADA
IPC: C07K14/71
Filed: 2021-11-01
Abstract: The present disclosure relates to combination therapies useful for the treatment of cancer. In particular, the invention relates to the combined use of a PD-1 inhibitor, a TGF-beta inhibitor, and a MCT4 inhibitor to treat cancer.
Patent AU-2021387794-A1 (AU)
Title: Herbicidal malonamides
Inventor: ZIMMERMANN GUNTHER
IPC: C07D493/18
Filed: 2021-11-24
Abstract: The present invention relates to malonamide compounds of the formula (I) wherein the variables are as defined in the claims and the description, and to compositions comprising these compounds. The invention also relates to the use of said malonamide compounds or the corresponding compositions for controlling unwanted vegetation. Furthermore, the invention relates to methods for controlling unwanted vegetation wherein said malonamide compounds or the corresponding compositions are applied.
Patent AU-2021400610-A1 (AU)
Title: Reinforcing glass fiber, chopped strand, fiber sheet, and rod
Inventor: KAWAGUCHI SATORU
IPC: C03C13/00
Filed: 2021-12-13
Abstract: The present invention provides a novel reinforcing glass fiber suitable for reinforcing various products. The reinforcing glass fiber according to the present invention contains SiO
Patent AU-2021414197-A1 (AU)
Title: Functionalisation of medical devices
Inventor: PYTEL RACHEL
IPC: A61L29/08
Filed: 2021-12-29
Abstract: Methods of modifying medical devices and medical devices are disclosed, One embodiment of a method of modifying a medical device includes functionalizing a surface of the medical device using cold plasma. One embodiment of a medical device is obtained by a method of modifying a device that includes functionalizing a surface of the medical device using cold plasma.
Patent AU-2022203208-A1 (AU)
Title: Internal dual pawl mechanism for indexable motorized ratchet tools
Inventor: BEER JOSHUA M
IPC: B25B13/46
Filed: 2022-05-13
Abstract: A pawl mechanism for an indexable tool and adapted to selectively transmit rotational 
motion of a yoke of the tool to a drive lug of the tool in one of first and second rotational 
directions. The pawl mechanism including a pawl carrier, first and second pawls pivotably 
coupled to the pawl carrier, and a selector switch rotatably coupled to the pawl carrier and 
adapted to selectively position the first and second pawls to transmit rotational motion of the 
yoke to the drive lug in one of the first and second rotational directions.  
18708178_1 (GHMatters) P118924.AU
1/7 
bd CO) 
CO 
co 
N 
0N 
C) 
0 (.0 
CN 
CO4
Patent AU-2022203232-A1 (AU)
Title: Applications, systems and methods to monitor, filter and/or alter output of a computing device
Inventor: HOLM MICHAEL
IPC: G06F17/00
Filed: 2022-05-13
Abstract: Applications, Systems and Methods to Monitor, Filter and/or Alter Output 
of a Computing Device 
ABSTRACT 
A system for to monitor image input of a computing device having a control circuit with a 
program- mable processor, and configured to receive images and to output the images to an image 
output device coupled to the computing device. The computing device can be configured to 
monitor the received images via the processor of the computing device being programmed using 
a Machine Learning Image Classification (MLIC) algorithm con- figured to determine a score of 
at least one received image within a predetermined criteria for classifying said at least one received 
image as a restricted subject image. Based on determination of the score, a modify or non-modify 
com- mand is generated; and wherein in response to said at least one received image being scored 
by said processor within the modify criteria, the processor is programmed to gener- ate a command 
to output the modified image.
Patent AU-2022203925-A1 (AU)
Title: Tissue specimen removal device, system and method
Inventor: JOHNSON DIRK
IPC: A61B18/00
Filed: 2022-06-06
Abstract: A tissue specimen removal device comprises a specimen bag; a flexible ring, the 
flexible ring configured to form a top opening of the specimen bag; a cannula assembly 
comprising: an inner tube portion and an outer tube portion. The device may further comprise 
a connector carrier, the connector carrier configured to retain at least one connector housing, 
the at least one connector housing comprising one or more connector portions and reside 
within an interior of the connector carrier, and wherein the connector carrier can be moved 
from a position within the cannula assembly to outside the cannula assembly.
Patent AU-2022212571-A1 (AU)
Title: Oral liposomal compositions
Inventor: RENAULT JEAN-YVES
IPC: A61K9/00
Filed: 2022-01-28
Abstract: The invention relates to a liposomal composition for oral, nasal or pulmonary administration, comprising a negatively charged phospholipid, optionally a zwitterionic phospholipid, a sterol, and one or more amphiphilic substances of biological interest, preferably a lipophilic immunostimulant useful for treating and/or preventing any pathology involving activation of monocytes and/or macrophages.
Patent AU-2022256793-A1 (AU)
Title: Co-regeneration recalcitrant plants
Inventor: STUURMAN JEROEN
IPC: A01H4/00
Filed: 2022-04-15
Abstract: The invention concerns a method for producing a shoot of a plant comprising germline progenitor cells of a recalcitrant plant. The germline progenitor cells may be modified to comprise a mutation in a sequence of interest. The invention further pertains to plants obtainable by the method of the invention, wherein the plant preferably comprises at least the L2-meristem layer of the recalcitrant plant.
Patent AU-2022277748-A1 (AU)
Title: Improved method for preparation of protein-enriched products from plant material
Inventor: WNUKOWSKI PIOTR
IPC: A23J1/00
Filed: 2022-05-16
Abstract: The present invention relates to a process for preparation of protein-enriched products, such as plant protein isolates or protein-fibre formulations, from plant materials such as oilseeds, as well as to the uses of the products obtainable via said process in human food and/or animal feed. In particular, the presented herein processes advantageously make use of solvents based on low-boiling azeotropic mixtures made of an apolar and lipophilic organic ester having up to 5 carbon atoms, with an alcohol having up to 5 carbon atoms, which solvents not only make the need to use noxious hexane-based solvents obsolete, but also can undergo reutilisation cycles by being easily obtainable and recoverable from spent solvents and/or mother liquors as used in the presented herein processes, and consequently render the disclosed processes extremely energy-efficient, suitable for large-scale industrial production, as well as eco-friendly.
Patent AU-2022283648-A1 (AU)
Title: Hierarchical context in risk assessment using machine learning
Inventor: LI XIN
IPC: G06V10/70
Filed: 2022-12-06
Abstract: HIERARCHICAL CONTEXT IN RISK ASSESSMENT 
USING MACHINE LEARNING 
ABSTRACT 
Methods, systems, and apparatus for receiving a request for a risk assessment for a 
parcel, receiving a set of images for the parcel, the set of images including two or more 
images, each image having an image scale and an image resolution that is different from 
other images in the set of images, providing a first-level feature embedding and a second
level feature embedding, the first-level feature embedding being provided by processing a 
first-level image through a first-level machine learning (ML) model, and the second-level 
feature embedding being provided by processing a second-level image through a second
level ML model, determining a risk assessment at least partially by processing each of the 
first-level feature embedding and a second-level feature embedding through a fusion 
network, and providing a representation of the risk assessment for display.